doxepin has been researched along with Hoarseness in 1 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
Hoarseness: An unnaturally deep or rough quality of voice.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rhoads, JM | 1 |
| Lowell, SH | 1 |
| Hedgepeth, EM | 1 |
1 other study available for doxepin and Hoarseness
| Article | Year |
|---|---|
Hoarseness and aphonia as a side effect of tricyclic antidepressants.
Topics: Antidepressive Agents, Tricyclic; Aphonia; Doxepin; Hoarseness; Humans; Male; Middle Aged; Nortripty | 1979 |